TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18715214

Group type: EXPERIMENTAL
Intervention: Sensor group (SG) - pump therapy with real-time continuous glucose monitoring (CGM)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (CG) - pump therapy and self-monitoring of blood glucose only
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Sensor group (SG)
Number of subjects: 146
Study: 15757423

Group type: EXPERIMENTAL
Intervention: Benazepril plus amlodipine (40/10 mg)
Number of subjects: 12600

Group type: COMPARATOR
Intervention: Benazepril plus hydrochlorothiazide (40/25 mg)
Number of subjects: 12600
Study: 12859086

Group type: EXPERIMENTAL
Intervention: Z100
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Clearfil Ray‐Posterior
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Prisma TPH
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: All materials
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Failed restorations
Number of subjects: 38
Study: 10842904

Group type: EXPERIMENTAL
Intervention: Soapsuds enema
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tap water enema
Number of subjects: 0
Study: 8874241

Group type: EXPERIMENTAL
Intervention: Dornase alfa (2.5 mg once daily)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo (once daily)
Number of subjects: 320
Study: 1847721

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 12
Study: 6198311

Group type: EXPERIMENTAL
Intervention: 4 Gy in 6 fractions over 3 weeks with 2 fractions per week
Number of subjects: 57

Group type: COMPARATOR
Intervention: 10 Gy in 2 fractions with an interval of one week
Number of subjects: 57
Study: 31902864

Group type: EXPERIMENTAL
Intervention: Tryptophan, vitamin B6, and nicotinamide-containing supplements
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo supplements
Number of subjects: 30
Study: 30081500

Group type: EXPERIMENTAL
Intervention: Fluoxetine + Magnesium (120 mg/day as magnesium aspartate)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Fluoxetine + Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fluoxetine + Magnesium
Number of subjects: 37
Study: 27372462

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 25113781

Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6 MWT)
Number of subjects: 47
Study: 21855289

Group type: EXPERIMENTAL
Intervention: Levosimendan added to dopamine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dobutamine added to dopamine
Number of subjects: 30
Study: 19330561

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17785038

Group type: EXPERIMENTAL
Intervention: Continuous combined hormone replacement therapy (ccHRT) with estradiol valerate (E2V) and medroxyprogesterone acetate (MPA)
Number of subjects: 459
Study: 16187809

Group type: EXPERIMENTAL
Intervention: Brief Motivational Interview (BMI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Alcohol Education session (AE)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 64
Study: 12482211

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg per os, evening assumption)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol (40 mg bid per os)
Number of subjects: 0
Study: 9665214

Group type: EXPERIMENTAL
Intervention: 2-month high-intensity residential rehabilitation program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 20
Study: 7726479

Group type: EXPERIMENTAL
Intervention: Cefotiam Hexetil (CTM) 200 mg bid
Number of subjects: 122

Group type: COMPARATOR
Intervention: Cefixime (CX) 200 mg bid
Number of subjects: 122
Study: 2572265

Group type: EXPERIMENTAL
Intervention: xamoterol
Number of subjects: 14
Study: 30937667

Group type: EXPERIMENTAL
Intervention: Integrated for Causation video
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Integrated in Sequence video
Number of subjects: 66

Group type: COMPARATOR
Intervention: Procedural Only video
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Integrated instructional videos (both Integrated for Causation and Integrated in Sequence)
Number of subjects: 66
Study: 28500081

Group type: EXPERIMENTAL
Intervention: Low-load blood flow restriction (BFR) training at 30% of 1 repetition maximum (1RM)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard quadriceps strengthening at 70% of 1 repetition maximum (1RM)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Low-load blood flow restriction (BFR) training
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard quadriceps strengthening
Number of subjects: 79
Study: 26275779

Group type: EXPERIMENTAL
Intervention: Filtered Technetium Sulfur Colloid (fTcSC)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Technetium Tilmanocept (TcTM)
Number of subjects: 52
Study: 24034570

Group type: EXPERIMENTAL
Intervention: Thermally oxidized sunflower oil (TOSO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unheated sunflower oil (Control)
Number of subjects: 20
Study: 22040589

Group type: EXPERIMENTAL
Intervention: Parents Speak Up National Campaign (PSUNC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19390842

Group type: EXPERIMENTAL
Intervention: 14-day contingent payment for smoking abstinence (14C)
Number of subjects: 34

Group type: COMPARATOR
Intervention: 1-day contingent payment for smoking abstinence (1C)
Number of subjects: 34
Study: 16958094

Group type: EXPERIMENTAL
Intervention: Ropinirole monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ropinirole with supplementary levodopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levodopa monotherapy
Number of subjects: 0
Study: 15195032

Group type: EXPERIMENTAL
Intervention: Serenoa repens (320 mg/die of Permixon) for at least 8 weeks before TURP
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no medical treatment before intervention)
Number of subjects: 108
Study: 12086556

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 9700993

Group type: EXPERIMENTAL
Intervention: ITF-296 (0.3, 1.0, or 3.0 microg/kg/min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ITF-296
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ITF-296 (1.0 and 3.0 microg/kg/min)
Number of subjects: 24
Study: 8024448

Group type: EXPERIMENTAL
Intervention: Laparoscopic sonography (LS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intraoperative cholangiography (IOC)
Number of subjects: 100
Study: 2601868

Group type: EXPERIMENTAL
Intervention: 1 g of naproxene + 2 g of rosaprostol
Number of subjects: 22

Group type: COMPARATOR
Intervention: 1 g of naproxene + placebo
Number of subjects: 22
Study: 31831529

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 105

Group type: COMPARATOR
Intervention: Mannitol
Number of subjects: 105
Study: 29020783

Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa (Elonva) 100 µg for women younger than 36 years and less than 60 kg; 150 µg for women older than 36 years or heavier than 60 kg, combined with GnRH antagonists.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa and GnRH antagonists
Number of subjects: 40
Study: 26162813

Group type: EXPERIMENTAL
Intervention: Group A: Rehabilitation with 20 minutes of hot packs and 15 minutes of intermittent cervical traction three times/week for 6 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group B: Same rehabilitation as Group A plus ESWT (2000 impulses, 0.27 mJ/mm(2)) over the calcified NL guided by X-ray
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group C: Same treatment as Group B but ESWT guided by musculoskeletal sonography
Number of subjects: 60
Study: 23569036

Group type: EXPERIMENTAL
Intervention: Conventional exercise plus proprioception and cognitive exercises
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional exercise
Number of subjects: 100
Study: 21495079

Group type: EXPERIMENTAL
Intervention: IMPACT collaborative care
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1801
Study: 19210062

Group type: EXPERIMENTAL
Intervention: Repetition of persuasive arguments (seen once or twice)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Greater controlled processing (reflecting argument content)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Greater automatic influence of familiarity (reflecting repetition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Greater controlled processing
Number of subjects: 0
Study: 16713435

Group type: EXPERIMENTAL
Intervention: Simvastatin, 80 mg/d
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15269144

Group type: EXPERIMENTAL
Intervention: BEC2 anti-idiotypic monoclonal antibody vaccine (25-microg dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GD3-lactone-KLH (GD3-L-KLH) vaccine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall immunization with either vaccine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cellular responses
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GD3-L-KLH vaccine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BEC2 vaccine
Number of subjects: 24
Study: 11137835

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 29
Study: 9210011

Group type: EXPERIMENTAL
Intervention: Disclosure to a male confidant
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Disclosure to a female confidante
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Writing the secret
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Correlation between intimacy of disclosure and level of homophobia
Number of subjects: 75
Study: 7962344

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol combined with 2.5 mg dydrogesterone
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol combined with 5 mg dydrogesterone
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol combined with 10 mg dydrogesterone
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol combined with 15 mg dydrogesterone
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol combined with all doses of dydrogesterone
Number of subjects: 165
Study: 31553374

Group type: EXPERIMENTAL
Intervention: Isolated and combined warm shower bath and perineal exercise with Swiss ball
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Warm shower bath
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Perineal exercise with Swiss ball
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Combined bath and ball
Number of subjects: 128
Study: 28129748

Group type: EXPERIMENTAL
Intervention: Faster rate of increase in milk feeds (30 ml/kg/day)
Number of subjects: 2800

Group type: COMPARATOR
Intervention: Slower rate of increase in milk feeds (18 ml/kg/day)
Number of subjects: 2800
Study: 25930719

Group type: EXPERIMENTAL
Intervention: Upfront zoledronic acid (ZA) 4 mg IV every 6 months
Number of subjects: 551

Group type: COMPARATOR
Intervention: Delayed zoledronic acid (ZA) 4 mg IV every 6 months
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Upfront zoledronic acid (ZA)
Number of subjects: 551

Group type: COMPARATOR
Intervention: Delayed zoledronic acid (ZA)
Number of subjects: 551
Study: 22268726

Group type: EXPERIMENTAL
Intervention: Long-pulsed 1064-nm Nd:YAG laser at 30 msec pulse width and fluence of 34 J/cm²; treated for three consecutive sessions at 4-week intervals.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (contralateral arm without treatment)
Number of subjects: 18
Study: 21865084

Group type: EXPERIMENTAL
Intervention: cobas HPV test
Number of subjects: 41955

Group type: COMPARATOR
Intervention: liquid-based cytology
Number of subjects: 41955

Group type: EXPERIMENTAL
Intervention: cobas HPV test + liquid-based cytology
Number of subjects: 41955

Group type: EXPERIMENTAL
Intervention: detection of HPV16, HPV18, or both
Number of subjects: 41955

Group type: COMPARATOR
Intervention: ASC-US or worse cytology
Number of subjects: 41955

Group type: EXPERIMENTAL
Intervention: detection of HPV16, HPV18, or both or low-grade squamous intraepithelial lesion or worse cytology
Number of subjects: 41955

Group type: EXPERIMENTAL
Intervention: detection of HPV16, HPV18, or both or high-grade squamous intraepithelial lesion or worse cytology
Number of subjects: 41955
Study: 18648895

Group type: EXPERIMENTAL
Intervention: On‐Q pump systems filled with 0.375% bupivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.9% normal saline (control)
Number of subjects: 30
Study: 16566936

Group type: EXPERIMENTAL
Intervention: Hypnosis during embryo transfer (ET)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Regular IVF/ET cycles (Control)
Number of subjects: 194
Study: 14520284

Group type: EXPERIMENTAL
Intervention: 0.25 mg of flunitrazepam (F0.25 group)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.5 mg of flunitrazepam (F0.5 group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 75
Study: 11031393

Group type: EXPERIMENTAL
Intervention: Valacyclovir hydrochloride (1 g 3 times daily) for 7 days
Number of subjects: 597

Group type: COMPARATOR
Intervention: Famciclovir (500 mg 3 times daily) for 7 days
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Valacyclovir hydrochloride
Number of subjects: 597

Group type: COMPARATOR
Intervention: Famciclovir
Number of subjects: 597
Study: 8741812

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 39

Group type: COMPARATOR
Intervention: Regular human insulin
Number of subjects: 39
Study: 1424650

Group type: EXPERIMENTAL
Intervention: Epidermal growth factor (EGF)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (drug vehicle)
Number of subjects: 104
Study: 3937820

Group type: EXPERIMENTAL
Intervention: Misoprostol 50 micrograms
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cimetidine 300 mg
Number of subjects: 32
Study: 30035341

Group type: EXPERIMENTAL
Intervention: TAP‐O
Number of subjects: 21
Study: 29363159

Group type: EXPERIMENTAL
Intervention: Aerobic games programme (EG)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 111
Study: 26964554

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure therapy (CPAP) for 24 weeks
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (AHI < 5 and AHI 5-15)
Number of subjects: 162
Study: 25410198

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care activity
Number of subjects: 0
Study: 22722504

Group type: EXPERIMENTAL
Intervention: ziprasidone 40 to 80 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ziprasidone 120 to 160 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ziprasidone 40 to 160 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 20147715

Group type: EXPERIMENTAL
Intervention: Balloon angioplasty plus stent graft
Number of subjects: 190

Group type: COMPARATOR
Intervention: Balloon angioplasty alone
Number of subjects: 190
Study: 17591032

Group type: EXPERIMENTAL
Intervention: Emtricitabine, didanosine and efavirenz
Number of subjects: 40
Study: 15501922

Group type: EXPERIMENTAL
Intervention: Moderate exercise (20-min treadmill at 65-70% peak oxygen consumption)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 0
Study: 12053117

Group type: EXPERIMENTAL
Intervention: Visual-processing speed assessment
Number of subjects: 173

Group type: COMPARATOR
Intervention: Everyday Problems Test
Number of subjects: 173

Group type: COMPARATOR
Intervention: Observed Tasks of Daily Living
Number of subjects: 173
Study: 9469359

Group type: COMPARATOR
Intervention: BEP/EP chemotherapy regimen (bleomycin, etoposide, and cisplatin)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: BOP/VIP-B chemotherapy regimen (bleomycin, vincristine, cisplatin / etoposide, ifosfamide, cisplatin, and bleomycin)
Number of subjects: 380

Group type: COMPARATOR
Intervention: BEP/EP
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: BOP/VIP-B
Number of subjects: 380
Study: 7665441

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH), 10 mg single dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2470768

Group type: EXPERIMENTAL
Intervention: Video instruction
Number of subjects: 150

Group type: COMPARATOR
Intervention: Personal tuition by a pharmacist
Number of subjects: 150

Group type: COMPARATOR
Intervention: Manufacturer's package insert
Number of subjects: 150
Study: 778483

Group type: EXPERIMENTAL
Intervention: Dextran
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Small doses of s.c. heparin
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 31
Study: 30347011

Group type: EXPERIMENTAL
Intervention: Active DLPFC stimulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16
Study: 28224289

Group type: EXPERIMENTAL
Intervention: Frontalis suspension using Gore-Tex through a skin crease incision (group I)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Frontalis suspension using Gore-Tex through supraciliary incisions (group II)
Number of subjects: 13
Study: 25886787

Group type: EXPERIMENTAL
Intervention: 7-Valent Pneumococcal Conjugate Vaccine
Number of subjects: 0
Study: 24002213

Group type: EXPERIMENTAL
Intervention: CB formulation (Curcuma longa and Boswellia serrata extracts) 500 mg twice a day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Celecoxib 100 mg twice a day
Number of subjects: 30
Study: 21385602

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg in 12 h)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Exercise in 30°C
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 11
Study: 19472440

Group type: EXPERIMENTAL
Intervention: Fixed combination of acetylsalicylic acid + paracetamol + caffeine
Number of subjects: 1734

Group type: EXPERIMENTAL
Intervention: Time to 50% pain relief (primary endpoint)
Number of subjects: 1734

Group type: EXPERIMENTAL
Intervention: Sum of pain intensity difference
Number of subjects: 1734

Group type: EXPERIMENTAL
Intervention: Reduction of pain intensity to 10 mm on visual analog scale
Number of subjects: 1734

Group type: EXPERIMENTAL
Intervention: Pain reduction by 50% within 1 hour after drug intake
Number of subjects: 1734

Group type: EXPERIMENTAL
Intervention: Time to be pain-free
Number of subjects: 1734
Study: 18043308

Group type: EXPERIMENTAL
Intervention: 6-month aerobic exercise training programme (four times/week, 45-60 min/session)
Number of subjects: 60
Study: 14513922

Group type: EXPERIMENTAL
Intervention: 52 g tryptophan depleting amino-acid drink
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 20
Study: 11071421

Group type: EXPERIMENTAL
Intervention: ECHO36 (lemon-lime ECHO with 36 mEq/L NaCl)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ECHO18 (lemon-lime ECHO with 18 mEq/L NaCl)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Water (lime colored water)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (lemon-lime placebo)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ECHO36
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ECHO18
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: COMPARATOR
Intervention: Water
Number of subjects: 18
Study: 9168215

Group type: EXPERIMENTAL
Intervention: Head-down tilt position
Number of subjects: 34

Group type: COMPARATOR
Intervention: Horizontal position
Number of subjects: 34
Study: 1729974

Group type: EXPERIMENTAL
Intervention: Upper extremity aerobic exercise program (3 times a week for 20 minutes at 70%-75% heart rate reserve)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-exercised control group (N=10)
Number of subjects: 10
Study: 3777103

Group type: EXPERIMENTAL
Intervention: Differential block placement during the Space Visualization test (SV)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Space Visualization (SV) adjusted scores
Number of subjects: 71
Study: 31641005

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate for 12 hours after diagnosis
Number of subjects: 2089

Group type: COMPARATOR
Intervention: Magnesium sulfate for 24 hours after diagnosis
Number of subjects: 2089
Study: 29323831

Group type: EXPERIMENTAL
Intervention: Bicycling intervention led by a certified instructor for 12 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bicycling intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 26474864

Group type: EXPERIMENTAL
Intervention: Inhaled Fluticasone Furoate (FF)
Number of subjects: 1225

Group type: EXPERIMENTAL
Intervention: Inhaled Vilanterol (VI)
Number of subjects: 1225

Group type: EXPERIMENTAL
Intervention: Combination of FF and VI (FF/VI)
Number of subjects: 1225
Study: 24584918

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) 400 mg (loading dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22677458

Group type: EXPERIMENTAL
Intervention: 12-Step peer intervention (PI)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: doctor intervention (DI)
Number of subjects: 151

Group type: COMPARATOR
Intervention: no intervention (NI)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: inpatient meeting attenders
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: post-discharge meeting attenders
Number of subjects: 151
Study: 18295212

Group type: EXPERIMENTAL
Intervention: Misoprostol (800 microg) administered vaginally
Number of subjects: 140

Group type: COMPARATOR
Intervention: Suction evacuation (surgical method)
Number of subjects: 140